Role of ryanodine receptor as a Ca2+ regulatory center in normal and failing hearts

Journal of Cardiology

Volumn 53, Issue 1, 2009, Pages 1-7

  Yano, Masafumi ^a   Yamamoto, Takeshi ^a   Kobayashi, Shigeki ^a   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ca2+ handling; Heart failure; Ryanodine receptor; Sarcoplasmic reticulum

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; CALMODULIN; CALSEQUESTRIN; FK 506 BINDING PROTEIN; RYANODINE RECEPTOR 2; SCAFFOLD PROTEIN;

AMINO ACID SEQUENCE; CALCIUM TRANSPORT; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHANNEL GATING; DIASTOLE; GENE MUTATION; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART FAILURE; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; NONHUMAN; PATHOGENESIS; REVIEW; SARCOPLASMIC RETICULUM;

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CALCIUM; CALCIUM CHANNELS; HEART FAILURE; HUMANS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; TACHYCARDIA, VENTRICULAR;

EID: 58249125804     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.10.008     Document Type: Review

References (49)

1. Braunwald E., and Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 102 (2000) IV14-IV23
2. Hasenfuss G., and Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol 34 (2002) 951-969
3. 2+ handling in heart failure. J Clin Invest 115 (2005) 556-564
4. Bers D.M. Macromolecular complexes regulating cardiac ryanodine receptor function. J Mol Cell Cardiol 37 (2004) 417-429
5. Takeshima H., Nishimura S., Matsumoto T., Ishida H., Kangawa K., Minamino N., Matsuo H., Ueda M., Hanaoka M., Hirose T., and Numa S. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 339 (1989) 439-445
6. 2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem 265 (1990) 13472-13483
7. Hakamata Y., Nakai J., Takeshima H., and Imoto K. Primary structure and distribution of a novel ryanodine receptor/calcium release channel from rabbit brain. FEBS Lett 312 (1992) 229-235
8. Marks A.R. Ryanodine receptors, FKBP12, and heart failure. Front Biosci 7 (2002) d970-977
9. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., and Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
10. Yano M., Ono K., Ohkusa T., Suetsugu M., Kohno M., Hisaoka T., Kobayashi S., Hisamatsu Y., Yamamoto T., Kohno M., Noguchi N., Takasawa S., Okamoto H., and Matsuzaki M. Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure. Circulation 102 (2000) 2131-2136
11. Lehnart S.E., Wehrens X.H., Reiken S., Warrier S., Belevych A.E., Harvey R.D., Richter W., Jin S.L., Conti M., and Marks A.R. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 123 (2005) 25-35
12. 2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6). Circ Res 94 (2004) 487-495
13. Stange M., Xu L., Balshaw D., Yamaguchi N., and Meissner G. Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. J Biol Chem 278 (2003) 51693-51702
14. Xiao B., Zhong G., Obayashi M., Yang D., Chen K., Walsh M.P., Shimoni Y., Cheng H., Ter Keurs H., and Chen S.R. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts. Biochem J 396 (2006) 7-16
15. 2+ release. J Biol Chem 282 (2007) 30256-30264
16. 2+ release (SOICR). Proc Natl Acad Sci USA 101 (2004) 13062-13067
17. 2+ release channel (ryanodine receptor). Biophys J 69 (1995) 106-119
18. Balshaw D.M., Xu L., Yamaguchi N., Pasek D.A., and Meissner G. Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor). J Biol Chem 276 (2001) 20144-20153
19. Yamaguchi N., Xu L., Pasek D.A., Evans K.E., and Meissner G. Molecular basis of calmodulin binding to cardiac muscle Ca(2+) release channel (ryanodine receptor). J Biol Chem 278 (2003) 23480-23486
20. Rodney G.G., Williams B.Y., Strasburg G.M., Beckingham K., and Hamilton S.L. Regulation of RYR1 activity by Ca(2+) and calmodulin. Biochemistry 39 (2000) 7807-7812
21. 2+ release channel, ryanodine receptor. J Biol Chem 276 (2001) 22579-22585
22. Yamaguchi N., Takahashi N., Xu L., Smithies O., and Meissner G. Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel. J Clin Invest 117 (2007) 1344-1353
23. Zhang T., Kohlhaas M., Backs J., Mishra S., Phillips W., Dybkova N., Chang S., Ling H., Bers D.M., Maier L.S., Olson E.N., and Brown J.H. CaMK II delta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J Biol Chem 282 (2007) 35078-35087
24. 2+ release. Circ Res 92 (2003) 904-911
25. 2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin. J Biol Chem 263 (1988) 1376-1381
26. Györke S., and Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovasc Res 77 (2008) 245-255
27. Györke I., Hester N., Jones L.R., and Györke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 86 (2004) 2121-2128
28. Sato Y., Ferguson D.G., Sako H., Dorn II G.W., Kadambi V.J., Yatani A., Hoit B.D., Walsh R.A., and Kranias E.G. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem 273 (1998) 28470-28477
29. Lahat H., Pras E., and Eldar M. A missense mutation in CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Ann Med 36 (2004) 87-91
30. Terentyev D., Nori A., Santoro M., Viatchenko-Karpinski S., Kubalova Z., Gyorke I., Terentyeva R., Vedamoorthyrao S., Blom N.A., Valle G., Napolitano C., Williams S.C., Volpe P., Priori S.G., and Gyorke S. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ Res 98 (2006) 1151-1158
31. di Barletta M.R., Viatchenko-Karpinski S., Nori A., Memmi M., Terentyev D., Turcato F., Valle G., Rizzi N., Napolitano C., Gyorke S., Volpe P., and Priori S.G. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 114 (2006) 1012-1019
32. Postma A.V., Denjoy I., Hoorntje T.M., Lupoglazoff J.M., Da Costa A., Sebillon P., Mannens M.M., Wilde A.A., and Guicheney P. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 91 (2002) e21-26
33. 2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 116 (2006) 2510-2520
34. Song L., Alcalai R., Arad M., Wolf C.M., Toka O., Conner D.A., Berul C.I., Eldar M., Seidman C.E., and Seidman J.G. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 117 (2007) 1814-1823
35. 2+ and phosphorylation. Biophys J 88 (2005) 3444-3454
36. Ikemoto N., and Yamamoto T. Regulation of calcium release by interdomain interaction within ryanodine receptors. Front Biosci 7 (2002) d671-683
37. Oda T., Yano M., Yamamoto T., Tokuhisa T., Okuda S., Doi M., Ohkusa T., Ikeda Y., Kobayashi S., Ikemoto N., and Matsuzaki M. Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure. Circulation 111 (2005) 3400-3410
38. Liu Z., Wang R., Zhang J., Chen S.R., and Wagenknecht T. Localization of a disease-associated mutation site in the three-dimensional structure of the cardiac muscle ryanodine receptor. J Biol Chem 280 (2005) 37941-37947
39. Meng X., Xiao B., Cai S., Huang X., Li F., Bolstad J., Trujillo R., Airey J., Chen S.R., Wagenknecht T., and Liu Z. Three-dimensional localization of serine 2808, a phosphorylation site in cardiac ryanodine receptor. J Biol Chem 282 (2007) 25929-25939
40. 2+ release channel dysfunction. Circ Res 98 (2006) 88-97
41. Cerrone M., Colombi B., Santoro M., di Barletta M.R., Scelsi M., Villani L., Napolitano C., and Priori S.G. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res 96 (2005) e77-e82
42. Kannankeril P.J., Mitchell B.M., Goonasekera S.A., Chelu M.G., Zhang W., Sood S., Kearney D.L., Danila C.I., De Biasi M., Wehrens X.H., Pautler R.G., Roden D.M., Taffet G.E., Dirksen R.T., Anderson M.E., et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc Natl Acad Sci USA 103 (2006) 12179-12184
43. 2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest 118 (2008) 2230-2245
44. Reiken S., Wehrens X.H., Vest J.A., Barbone A., Klotz S., Mancini D., Burkhoff D., and Marks A.R. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107 (2003) 2459-2466
45. Doi M., Yano M., Kobayashi S., Kohno M., Tokuhisa T., Okuda S., Suetsugu M., Hisamatsu Y., Ohkusa T., Kohno M., and Matsuzaki M. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor. Circulation 105 (2002) 1374-1379
46. Okuda S., Yano M., Doi M., Oda T., Tokuhisa T., Kohno M., Kobayashi S., Yamamoto T., Ohkusa T., and Matsuzaki M. Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure. Circulation 109 (2004) 911-999
47. Yano M., Kobayashi S., Kohno M., Doi M., Tokuhisa T., Okuda S., Suetsugu M., Hisaoka T., Obayashi M., Ohkusa T., Kohno M., and Matsuzaki M. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107 (2003) 477-484
48. Yamamoto T., Yano M., Xu X., Uchinoumi H., Tateishi H., Mochizuki M., Oda T., Kobayashi S., Ikemoto N., and Matsuzaki M. Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts. Circulation 117 (2008) 762-772
49. Wehrens X.H., Lehnart S.E., Reiken S.R., Deng S.X., Vest J.A., Cervantes D., Coromilas J., Landry D.W., and Marks A.R. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304 (2004) 292-296